KR20090059152A - 쿠프레독신으로 암을 예방하는 조성물과 방법 - Google Patents
쿠프레독신으로 암을 예방하는 조성물과 방법 Download PDFInfo
- Publication number
- KR20090059152A KR20090059152A KR1020097007352A KR20097007352A KR20090059152A KR 20090059152 A KR20090059152 A KR 20090059152A KR 1020097007352 A KR1020097007352 A KR 1020097007352A KR 20097007352 A KR20097007352 A KR 20097007352A KR 20090059152 A KR20090059152 A KR 20090059152A
- Authority
- KR
- South Korea
- Prior art keywords
- ala
- gly
- cupredoxin
- cancer
- val
- Prior art date
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/104—Pseudomonadales, e.g. Pseudomonas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US84435806P | 2006-09-14 | 2006-09-14 | |
US60/844,358 | 2006-09-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20090059152A true KR20090059152A (ko) | 2009-06-10 |
Family
ID=39184582
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020097007352A KR20090059152A (ko) | 2006-09-14 | 2007-09-13 | 쿠프레독신으로 암을 예방하는 조성물과 방법 |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP2061498A4 (ja) |
JP (2) | JP2010503409A (ja) |
KR (1) | KR20090059152A (ja) |
CN (1) | CN101595124A (ja) |
AU (1) | AU2007296429A1 (ja) |
BR (1) | BRPI0714987A2 (ja) |
CA (1) | CA2663498A1 (ja) |
IL (1) | IL197602A0 (ja) |
MX (1) | MX2009002787A (ja) |
NO (1) | NO20091267L (ja) |
RU (1) | RU2009113812A (ja) |
SG (1) | SG174784A1 (ja) |
WO (1) | WO2008033987A2 (ja) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7691383B2 (en) | 2004-10-07 | 2010-04-06 | The Board Of Trustees Of The University Of Illinois | Cupredoxin derived transport agents and methods of use thereof |
US7556810B2 (en) | 2005-07-19 | 2009-07-07 | The Board Of Trustees Of The University Of Ilinois | Compositions and methods to control angiogenesis with cupredoxins |
US9096663B2 (en) | 2001-02-15 | 2015-08-04 | The Board Of Trustees Of The University Of Illinois | Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereof |
US7381701B2 (en) | 2001-02-15 | 2008-06-03 | The Borad Of Trustees Of The University Of Illinois | Compositions and methods for treating conditions related to ephrin signaling with cupredoxins |
US10675326B2 (en) | 2004-10-07 | 2020-06-09 | The Board Of Trustees Of The University Of Illinois | Compositions comprising cupredoxins for treating cancer |
US9598470B2 (en) | 2004-10-07 | 2017-03-21 | Craig W. Beattie | Compositions and methods to prevent cancer by stabilizing P53 through non MDM2-mediated pathways |
US9434770B2 (en) | 2004-10-07 | 2016-09-06 | Tapas K Das Gupta | Modified cupredoxin derived peptides |
US9968685B2 (en) | 2004-10-07 | 2018-05-15 | Brad N. Taylor | Methods to treat cancer with cupredoxins |
EP1904642A4 (en) | 2005-07-19 | 2008-11-26 | Univ Illinois | TRANSPORT AGENTS USEFUL FOR CROSSING THE HEMATO-ENCEPHALIC BARRIER AND FOR PENETRATING IN CANCER CELLS OF THE BRAIN, METHODS OF USING THE SAME |
CA2671492A1 (en) | 2006-12-04 | 2008-06-12 | The Board Of Trustees Of The University Of Illinois | Compositions and methods to treat cancer with cupredoxins and cpg rich dna |
AU2008212788A1 (en) * | 2007-02-08 | 2008-08-14 | The Board Of Trustees Of The University Of Illinois | Compositions and methods to prevent cancer with cupredoxins |
AU2017433280A1 (en) * | 2017-09-29 | 2020-04-16 | Oncgnostics Gmbh | Risk determination for neoplasia and cancer |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7491394B2 (en) * | 2001-02-15 | 2009-02-17 | The Board Of Trustees Of The University Of Illinois | Cytotoxic factors for modulating cell death |
US7691383B2 (en) * | 2004-10-07 | 2010-04-06 | The Board Of Trustees Of The University Of Illinois | Cupredoxin derived transport agents and methods of use thereof |
CN1506375A (zh) * | 2002-12-12 | 2004-06-23 | 浙江养生堂天然药物研究所有限公司 | 具有广谱抗肿瘤作用的细菌蛋白天青蛋白及其用途和含有其的药物组合物 |
CA2608512A1 (en) * | 2005-05-20 | 2007-02-15 | The Board Of Trustees Of The University Of Illinois | Compositions and methods for treating conditions related to ephrin signaling with cupredoxins |
WO2007024368A2 (en) * | 2005-07-19 | 2007-03-01 | The Board Of Trustees Of The University Of Illinois | Compositions and methods to control angiogenesis with cupredoxins |
-
2007
- 2007-09-13 BR BRPI0714987-5A patent/BRPI0714987A2/pt not_active Application Discontinuation
- 2007-09-13 EP EP07842403A patent/EP2061498A4/en not_active Withdrawn
- 2007-09-13 AU AU2007296429A patent/AU2007296429A1/en not_active Abandoned
- 2007-09-13 JP JP2009528468A patent/JP2010503409A/ja not_active Withdrawn
- 2007-09-13 CN CNA2007800417624A patent/CN101595124A/zh active Pending
- 2007-09-13 SG SG2011064334A patent/SG174784A1/en unknown
- 2007-09-13 MX MX2009002787A patent/MX2009002787A/es not_active Application Discontinuation
- 2007-09-13 KR KR1020097007352A patent/KR20090059152A/ko not_active Application Discontinuation
- 2007-09-13 CA CA002663498A patent/CA2663498A1/en not_active Abandoned
- 2007-09-13 RU RU2009113812/10A patent/RU2009113812A/ru unknown
- 2007-09-13 WO PCT/US2007/078371 patent/WO2008033987A2/en active Application Filing
-
2009
- 2009-03-15 IL IL197602A patent/IL197602A0/en unknown
- 2009-03-26 NO NO20091267A patent/NO20091267L/no not_active Application Discontinuation
-
2013
- 2013-10-04 JP JP2013209725A patent/JP2014050390A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP2061498A4 (en) | 2009-11-04 |
NO20091267L (no) | 2009-06-04 |
JP2010503409A (ja) | 2010-02-04 |
WO2008033987A2 (en) | 2008-03-20 |
CA2663498A1 (en) | 2008-03-20 |
BRPI0714987A2 (pt) | 2013-07-30 |
RU2009113812A (ru) | 2010-10-20 |
MX2009002787A (es) | 2009-08-27 |
SG174784A1 (en) | 2011-10-28 |
WO2008033987A3 (en) | 2009-04-30 |
CN101595124A (zh) | 2009-12-02 |
IL197602A0 (en) | 2011-08-01 |
EP2061498A2 (en) | 2009-05-27 |
JP2014050390A (ja) | 2014-03-20 |
AU2007296429A1 (en) | 2008-03-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20090059152A (ko) | 쿠프레독신으로 암을 예방하는 조성물과 방법 | |
US10117905B2 (en) | Compositions and methods to prevent cancer with cupredoxins | |
US10086037B2 (en) | Compositions and methods to prevent cancer with cupredoxins | |
US10351605B2 (en) | Compositions and methods to prevent cancer by stabilizing p53 through non MDM2-mediated pathways | |
JP2014193886A (ja) | キュプレドキシン由来ペプチドの修飾及びそれを使用する方法 | |
KR20110120275A (ko) | 큐프레독신으로 암을 예방하기 위한 조성물 및 방법 | |
US8158574B2 (en) | Compositions and methods to prevent cancer with cupredoxins | |
KR20080019615A (ko) | 쿠프레독신과 시토크롬으로 말라리아를 치료하기 위한조성물과 방법 | |
KR20080024124A (ko) | 쿠프레독신과 시토크롬 c로 hiv 감염을 치료하기 위한조성물과 방법 | |
KR20080034905A (ko) | 쿠프레독신으로 혈관신생을 제어하는 조성물과 방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |